These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16312586)

  • 1. Serious, life-threatening infections: results with pefloxacin.
    Gargalianos P; Lelekis M; Lanaras L; Karakatsani E; Tsouroulas P; Kosmidis J
    J Chemother; 1989 Jul; 1(4 Suppl):672-3. PubMed ID: 16312586
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of ofloxacin taken orally in 19 severe infections.
    Potel G; Touze MD; Reynaud A; Courtieu AL; Baron D
    J Chemother; 1989 Jul; 1(4 Suppl):679-81. PubMed ID: 16312590
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effect of gentamicin and pefloxacin treatment on the late stages of mouse typhoid.
    Bonina L; Costa GB; Mastroeni P
    New Microbiol; 1998 Jan; 21(1):9-14. PubMed ID: 9497924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of pefloxacin in the treatment of postoperative sepsis in gynaecology.
    Arowojolu AO; Bakare RA; Oni AA; Ayodele AE; Kayode OO
    Afr J Med Med Sci; 1999; 28(3-4):151-3. PubMed ID: 11205820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pefloxacin in the treatment of acute severe infections in hospitalized patients. Clinical and bacteriological evaluation.
    Giustina A; Romanelli G; Cravarezza P; Ravizzola G; Turano A
    J Chemother; 1989 Jul; 1(4 Suppl):668-9. PubMed ID: 16312584
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical observations with Péflacine.
    Ludwig E; Székely E; Arr M
    Ther Hung; 1993; 41(4):128-31. PubMed ID: 8029779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pefloxacin in the treatment of severe infections in intensive care].
    Gritti G; Capuzzo M; Verri M; Nepoti ML; Nardini A
    Minerva Anestesiol; 1988 Sep; 54(9):367-72. PubMed ID: 3249624
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the effectiveness of the use of pefloxacin in combined radiation-thermal injury].
    Makarov GF; Budagov RS; Moiseeva LA; Boldueva NG
    Antibiot Khimioter; 1995 Aug; 40(8):36-9. PubMed ID: 8713436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doripenem (Doribax)--a new parenteral carbapenem.
    Med Lett Drugs Ther; 2008 Jan; 50(1278):5-7. PubMed ID: 18219262
    [No Abstract]   [Full Text] [Related]  

  • 10. Pefloxacin in the treatment of 24 suppurative infections.
    Desplaces N; Mamoudy P; Leonard P; Houdart R; Rouchy J; Kitzis M; Gutmann L
    Chemioterapia; 1987 Jun; 6(2 Suppl):394-5. PubMed ID: 3509457
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pefloxacin mesylate--clinical effectiveness in various forms of infectious-inflammatory diseases].
    Pozdniakova VP; Nestetrova LIa; Smirnova LB; Iakovlev VP; Blatun LA; Koshil' OI; Fedorov SM; Bakalova LA; Strachunskiĭ LS; Kurmanova KB
    Antibiot Khimioter; 1997; 42(7):20-3. PubMed ID: 9334143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bacterial endophthalmitis: treatment with a combination of fosfomycin and pefloxacin apropos of 9 cases].
    Salvanet-Bouccara A; Feys J; Koffi-Gue B; Fisch A; Cherifi M; Forestier F
    Bull Soc Ophtalmol Fr; 1989 Nov; 89(11):1281-6. PubMed ID: 2630133
    [No Abstract]   [Full Text] [Related]  

  • 13. Duration of antibiotic treatment: are even numbers odd?
    Alp E; van der Hoeven JG; Verweij PE; Mouton JW; Voss A
    J Antimicrob Chemother; 2005 Aug; 56(2):441-2. PubMed ID: 15980095
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experience with lower doses of cefotaxime in hospitalized patients with serious infections.
    Shah A; Madhavan T; Drelichman V; Price J
    J Chemother; 1989 Jul; 1(4 Suppl):650-1. PubMed ID: 16312575
    [No Abstract]   [Full Text] [Related]  

  • 15. [Criteria for the estimation of clinical effect of antimicrobial drugs in the treatment of infections associated with granulocytopenia].
    Takaku F; Nagai K; Maekawa T; Masaoka T
    Rinsho Ketsueki; 1984 Apr; 25(4):588-92. PubMed ID: 6471442
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of pefloxacin with ceftazidime in severe bronchopulmonary infections.
    Vanderdonckt J
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():111-6. PubMed ID: 2258338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further observations of the role of timentin in clinical practice.
    Shah A; Madhavan T; Drelichman V; Price J
    J Chemother; 1989 Jul; 1(4 Suppl):656-7. PubMed ID: 16312578
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequential parenteral oral antibiotic therapy for serious infections.
    Nelson JD
    Bull N Y Acad Med; 1983 Jun; 59(5):422-9. PubMed ID: 6576827
    [No Abstract]   [Full Text] [Related]  

  • 19. Colistin in the treatment of life-threatening infections.
    Pavleas J; Skiada A; Daikos GL; Rigas K; Mega A; Archondoulis N; Vernikos P; Salatas K; Thomopoulos G
    Int J Antimicrob Agents; 2006 Oct; 28(4):374-6. PubMed ID: 16963234
    [No Abstract]   [Full Text] [Related]  

  • 20. [Short-course antibiotic therapy: concepts and applications].
    Bastides F; Choutet P
    Rev Prat; 1998 Nov; 48(18):1977-9. PubMed ID: 9881005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.